These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 2510594)

  • 1. In vitro bactericidal activities of gentamicin, cefazolin, and imipenem in peritoneal dialysis fluids.
    Halstead DC; Guzzo J; Giardina JA; Geshan AE
    Antimicrob Agents Chemother; 1989 Sep; 33(9):1553-6. PubMed ID: 2510594
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of different peritoneal dialysis fluids on the in vitro activity of fosfomycin against Escherichia coli, Staphylococcus aureus, Staphylococcus epidermidis, and Pseudomonas aeruginosa.
    Kussmann M; Hauer S; Pichler P; Reznicek G; Burgmann H; Poeppl W; Zeitlinger M; Wiesholzer M
    Eur J Clin Microbiol Infect Dis; 2018 Jun; 37(6):1091-1098. PubMed ID: 29546637
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The use of intradiscal antibiotics for discography: an in vitro study of gentamicin, cefazolin, and clindamycin.
    Klessig HT; Showsh SA; Sekorski A
    Spine (Phila Pa 1976); 2003 Aug; 28(15):1735-8. PubMed ID: 12897501
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibiotic tolerance of peritoneal bacterial isolates in dialysis fluids.
    Zelenitsky S; Franczuk C; Fine A; Ariano R; Harding G
    J Antimicrob Chemother; 2002 May; 49(5):863-6. PubMed ID: 12003985
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro potency and stability of fortified ophthalmic antibiotics.
    Arici MK; Sümer Z; Güler C; Elibol O; Saygi G; Cetinkaya S
    Aust N Z J Ophthalmol; 1999 Dec; 27(6):426-30. PubMed ID: 10641902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of sulfur hexafluoride gas on antibacterial activity of antibiotics in vitro against agents causing endophthalmitis.
    Yanyali A; Cetin S; Talu H; Vahaboglu H
    Ophthalmologica; 2001; 215(6):439-43. PubMed ID: 11741112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro activity of fosfomycin-gentamicin, fosfomycin-ceftazidime, fosfomycin-imipenem and ceftazidime-gentamicin combinations against ceftazidime-resistant Pseudomonas aeruginosa.
    Pruekprasert P; Tunyapanit W
    Southeast Asian J Trop Med Public Health; 2005 Sep; 36(5):1239-42. PubMed ID: 16438151
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of intraperitoneal cefazolin and gentamicin in empiric therapy of peritonitis in continuous ambulatory peritoneal dialysis patients.
    Tosukhowong T; Eiam-Ong S; Thamutok K; Wittayalertpanya S; Na Ayudhya DP
    Perit Dial Int; 2001; 21(6):587-94. PubMed ID: 11783768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of peritoneal fluid culture results from adults and children undergoing CAPD.
    Yinnon AM; Gabay D; Raveh D; Schlesinger Y; Slotki I; Attias D; Rudensky B
    Perit Dial Int; 1999; 19(1):51-5. PubMed ID: 10201341
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of imipenem and five other antipseudomonal agents against gentamicin-susceptible and -resistant Pseudomonas aeruginosa.
    Gerçeker AA; Otük G
    Chemotherapy; 1995; 41(5):334-6. PubMed ID: 8521734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of peritonitis in continuous ambulatory peritoneal dialysis (CAPD) with intraperitoneal cefazolin and gentamicin.
    Weber J; Staerz E; Mettang T; Machleidt C; Kuhlmann U
    Perit Dial Int; 1989; 9(3):191-5. PubMed ID: 2488364
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Imipenem/gentamicin and imipenem/rifampin against methicillin-resistant Staphylococcus aureus.
    Watanakunakorn C
    Chemotherapy; 1991; 37(4):283-6. PubMed ID: 1790726
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative pharmacodynamics of gentamicin against Staphylococcus aureus and Pseudomonas aeruginosa.
    Tam VH; Kabbara S; Vo G; Schilling AN; Coyle EA
    Antimicrob Agents Chemother; 2006 Aug; 50(8):2626-31. PubMed ID: 16870751
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synergistic enhancement of in vitro antimicrobial activity of imipenem and cefazolin, cephalothin, cefotiam, cefamandole or cefoperazone in combination against methicillin-sensitive and -resistant Staphylococcus aureus.
    Uete T; Matsuo K
    Jpn J Antibiot; 1995 Mar; 48(3):402-8. PubMed ID: 7752453
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bacterial growth and killing in chronic ambulatory peritoneal dialysis fluids.
    Verbrugh HA; Keane WF; Conroy WE; Peterson PK
    J Clin Microbiol; 1984 Aug; 20(2):199-203. PubMed ID: 6386844
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microbiology of peritoneal dialysis-related infection and factors of refractory peritoneal dialysis related peritonitis: A ten-year single-center study in Taiwan.
    Wang HH; Huang CH; Kuo MC; Lin SY; Hsu CH; Lee CY; Chiu YW; Chen YH; Lu PL
    J Microbiol Immunol Infect; 2019 Oct; 52(5):752-759. PubMed ID: 30665844
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro evaluation of N-formimidoyl thienamycin (MK0787) combined with amikacin against gram-negative bacilli and Staphylococcus aureus.
    Díez Enciso M; Mateos Lindemann M; Gutiérrez Altés A
    Antimicrob Agents Chemother; 1982 Dec; 22(6):1064-6. PubMed ID: 6818899
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from patients with urinary tract infections (1996). I. Susceptibility distribution].
    Kumamoto Y; Tsukamoto T; Hirose T; Yokoo A; Shigeta S; Takahashi T; Shiraiwa Y; Ogiwara M; Yoshida H; Imafuku Y; Murai M; Watanabe K; Uchida H; Kobayashi Y; Matsuda S; Fujime M; Fujita K; Igari J; Oguri T; Yamaguchi K; Matsumoto T; Kashitani F; Kaku M; Ooe H; Mochida C
    Jpn J Antibiot; 1998 Feb; 51(2):69-111. PubMed ID: 9575437
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro antimicrobial activity of imipenem in combination with vancomycin or teicoplanin against Staphylococcus aureus and Staphylococcus epidermidis.
    Barr JG; Smyth ET; Hogg GM
    Eur J Clin Microbiol Infect Dis; 1990 Nov; 9(11):804-9. PubMed ID: 2150814
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antimicrobial synergism of piperacillin and gentamicin against pseudomonas aeruginosa, Staphylococcus aureus and Streptococcus faecalis.
    Bach VT; Webb DW; Thadepalli H
    Chemotherapy; 1980; 26(1):21-7. PubMed ID: 6766372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.